New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2012
16:16 EDTNSRGY, MYGN, AZN, TRGT, TSL, STP, YGE, TIF, RIO, BHPOn The Fly: Closing Wrap
Stocks on Wall Street were lower on concerns of slowing growth in China. The futures barely reacted to February U.S. housing data, which showed starts were lower than expected but building permits were higher. The futures action led to a lower open for the broader market. The averages found a level in the first 30 minutes of trading where they sat and eventually began to drift higher. The market moved generally higher until the last hour of the session but the averages were never able to retake the baseline to continue their six day winning streak... ECONOMIC EVENTS: In the U.S., homebuilders began construction on a seasonally adjusted annual rate of 698,000 homes in February, down 1.1% from a month ago. Building permits jumped 5.1%, versus expectations for an increase of 0.6%. In China, a report said that home prices dropped in 45 Chinese cities last month and the country increased its gas and diesel prices for the second time in less than six weeks... MARKET NEWS: BHP Billiton (BHP) was widely quoted as stating that Chinese iron ore demand growth was "flattening," but the company came out and said that the slowdown had been discussed before and was not new information. Also, both BHP and rival Rio Tinto (RIO) confirmed plans to expand production in China even further. Still, BHP's confirmation along with other signals of a slowdown in China was attributed as a significant catalyst for today's market pull-back... Saudi Arabia said it is ready to meet any shortfalls in global oil supplies which, along with China's news, caused oil prices to fall 2%, weighing on the Energy sector of the S&P... Amazon.com (AMZN) moved up 3.67% following its $775M purchase of Kiva Systems, a maker of robots and other material handling technology... MAJOR MOVERS: Among the notable gainers was Tiffany (TIF), up $4.59, or 6.68%, to $73.27, after its earnings missed expectations but its FY12 guidance beat the Street's view. Also higher were a number of Chinese solar companies, including Yingli Green Energy (YGE), up 46c, or 12.07%, to $4.27, Suntech (STP), up 44c, or 14.06%, to $3.57, and Trina Solar (TSL), up 61c, or 7.85%, to $8.38, following the U.S. Commerce Department's decision to impose tariffs of less than 5% on the companies, which was well below the 20% to 30% that was forecast by some analysts. Noteworthy losers included Targacept (TRGT), down $2.22, or 29.96%, to $5.19, after it abandoned plans to seek approval for a depression drug it was developing in partnership with AstraZeneca (AZN), and Myriad Genetics (MYGN), down $1.33, or 5.19%, to $24.31, after the Supreme Court ruled that two patents held by Nestle (NSRGY) for certain personalized medicine products are invalid because the patents utilize "laws of nature" without adding significant additional features to those laws... INDICES: The Dow fell 68.94, or 0.52%, to 13,170.19; the Nasdaq lost 4.17, or 0.14%, to 3,074.15; and the S&P 500 dropped 4.23, or 0.30%, to 1,405.52.
News For BHP;RIO;TIF;YGE;STP;TSL;TRGT;AZN;MYGN;NSRGY From The Last 14 Days
Check below for free stories on BHP;RIO;TIF;YGE;STP;TSL;TRGT;AZN;MYGN;NSRGY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 16, 2014
07:59 EDTAZNTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
05:15 EDTRIORio Tinto raises FY14 thermal coal production outlook to 17.5M tonnes
The company's previous thermal coal production guidance was 16.7M tons. This follows a change in the production profile to produce additional higher margin thermal coal from a processing plant by-product stream at Hail Creek. As a result of this change and lower than expected production during the ramp up at Kestrel, Australian hard coking coal production has decreased to 7.4M tonnes, previously 8.2M tonnes. Semi-soft coking coal production guidance remains unchanged at 3M tonnes.Rio Tinto’s share of uranium production across Rössing and ERA in 2014 is expected to be between 4.3M-5.1M pounds. This follows operational changes at Rössing in response to current market conditions. Progression to full processing capacity at ERA is anticipated in Q3. Reference Link
05:11 EDTRIORio Tinto reports Q2 global iron ore production up 11% to 73.1M tons
Subscribe for More Information
July 15, 2014
20:05 EDTRIORio Tinto iron ore output rose 10% in first half of year, WSJ reports
Subscribe for More Information
10:28 EDTTRGTHigh option volume stocks
High option volume stocks: TRGT ALB UUP ADHD ROC WWW CTRL KERX IMGN NI
07:04 EDTYGE, TSLWTO says U.S. tariffs on Chinese solar cells against rules, Xinhua reports
The World Trade Organization yesterday ruled that U.S. tariffs on Chinese solar cells violated the rules of the organization, according to Xinhua. China requested that the WTO probe the subsidies in 2012, the news service noted. The WTO also said that U.S. tariffs on Chinese steel products and paper violated the organization's rules, the news service added. Publicly traded solar energy companies include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).Reference Link
06:07 EDTYGEYingli Green Energy signs EPC contract with Senelec for 2 MW project
Subscribe for More Information
July 14, 2014
15:37 EDTTRGTTargacept resumes trading, down 12% following study failure
Subscribe for More Information
15:13 EDTTRGTTargacept to resume trading at 3:35 pm ET
Subscribe for More Information
15:08 EDTTRGTTargacept confirms Alzheimer’s trial does not show superiority of TC-1734
Targacept announced top-line results from a Phase 2b monotherapy clinical trial of TC-1734 as a treatment for mild to moderate Alzheimer’s disease. In the trial, TC-1734 did not meet the objective of showing superiority to donepezil, the marketed medication most often prescribed for Alzheimer’s disease, after 52 weeks of treatment. The trial did not include a placebo arm and was not designed to determine whether TC-1734 is equivalent to donepezil. The co-primary endpoints for the study were measures of cognitive function and global function. Consistent with previous clinical results, TC-1734 exhibited a benign safety and tolerability profile. Targacept President and CEO Dr. Stephen A. Hill said, “We are disappointed for Alzheimer’s disease patients and their families. We designed a rigorous study to provide a definitive answer on whether TC-1734 could be a better treatment option than the current standard of care in what has been a very difficult disease area for the development of novel therapeutics. Based on these results, we do not intend to invest in further development of TC-1734.” Analyses of the full dataset from the trial are ongoing and Targacept plans to present and publish more detailed results over the coming months, the company said.
15:08 EDTTRGTTargacept does not intend to invest in further TC-1734 development
Subscribe for More Information
15:08 EDTTRGTTargacept confirms Alzheimer’s trial does not show superiority of TC-1734
Subscribe for More Information
14:37 EDTTRGTTargacept Alzheimer's study said to fail, TheStreet's Feuerstein says
Subscribe for More Information
14:36 EDTTRGTTargacept halted for trading following reports of study failure
14:32 EDTTRGTTargacept halted for volatility after dropping 16% to $3.71
Subscribe for More Information
11:16 EDTTSL, YGEWTO finds U.S. violates trade rules with tariffs on Chinese steel, solar panels
Subscribe for More Information
07:04 EDTBHPExterran Partners to acquire natural gas compression assets from MidCon
Subscribe for More Information
July 10, 2014
09:31 EDTNSRGYNestle acquires rights to aesthetic dermatology products in the U.S. and Canada
Subscribe for More Information
09:31 EDTNSRGYValeant completes filler, toxin asset sale to Galderma
Subscribe for More Information
July 9, 2014
07:03 EDTTSLTrina Solar to supply 200MW PV modules to China's Zonergy
Trina Solar will supply 200MW of modules to Zonergy's downstream projects in China, marking its largest single module supply agreement to date in 2014. Module delivery is expected to be completed in December.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use